Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VALSARTAN USP, with a corresponding US DMF Number 18253.
Remarkably, this DMF maintains an Active status since its submission on April 07, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2013, and payment made on June 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II